Ectopic expression of the ErbB-3 binding protein Ebp1 inhibits growth and induces differentiation of human breast cancer cell lines

Journal of Cellular Physiology

Volumn 183, Issue 3, 2000, Pages 321-329

  Lessor, Tracy J ^a   Yoo, Joo Yeon ^a   Xia, Xianmin ^a   Woodford, Nicholas ^a   Hamburger, Anne W ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR;

ARTICLE; BREAST CANCER; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL DIVISION; FEMALE; GENES, REPORTER; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEUREGULIN-1; PROMOTER REGIONS (GENETICS); RECEPTOR, ERBB-3; RECOMBINANT PROTEINS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034054236     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O     Document Type: Article

References (38)

1. Alroy I, Soussan L, Seger R, Yarden Y. 1999. Neu Differentiation Factor stimulates phosphorylation and activation of the Sp1 transcription factor. Mol Cell Biol 19:1961-1972.
2. Aoudjit F, Brochu N, Belanger B, Stratowa C, Hiscrott J, Audette M. 1997. Regulation of the intercellular adhesion molecule-1 gene by tumor necrosis factor-α is mediated by the nuclear factor-κb heterodimers p65/p65 and p65/rel in the absence of p50. Cell Growth Differ 8:335-342.
3. Bacus SS, Kiguchi K, Chin D, King CR, Huberman E. 1990. Differentiation of cultured human breast cancer cells (Au-565 and MCF-7) associated with loss of cell surface HER-2/neu antigen. Mol Carcinog 3:350-362.
4. Bacus SS, Huberman E, Chin D, Kiguchi K, Simpson S, Lippman M, Lupu R. 1992. A ligand for the ErbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth Differ 3:401-411.
5. Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R, Wen D, Sela M, Yarden Y. 1993. Neu Differentiation Factor (heregulin) induces expression of intercellular adhesion molecule-1: implications for mammary tumors. Cancer Res 54:5251-5261.
6. Daly JM, Jannot CB, Beerli RR, Graus-Porta D, Maurer FG, Hynes NE. 1997. Neu Differentiation Factor induces ErbB-2 down-regulation and apoptosis of ErbB-2 overexpressing breast tumor cells. Cancer Res 57:3804-3811.
7. Daly JM, Olayioye M, Wong AML, Neve R, Lane HA, Maurer FG, Hynes NE. 1999. NDF/heregulin induced cell cycle changes and apoptosis in breast tumor cells: role of P13 kinase and p38 MAP kinase pathways. Oncogene 18:3440-3452.
8. Erickson SL, O'Shea KS, Ghaboosi N, Loverro L, Frantz G, Bauer M, Lu LH, Moore MW. 1997. ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2 and heregulin deficient mice. Development 124:4999-5011.
9. Fazioli F, Minichiello L, Matoska V, Castagnino P, Miki T, Wong WT, Di Fiore PP. 1993. Eps8, a substrate for the epidermal growth factor receptor kinase, enhances EGF-dependent mitogenic signals. EMBO J 12:3799-3808.
10. Fedi P, Pierce JP, Di Fiore PP, Kraus MH. 1994. Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C-γ or GTPase activating protein, distinguished erbB-3 signaling from that of other Erb/EGFR family members. Mol Cell Biol 14:492-500.
11. Fields S, Song O. 1989. A novel genetic system to detect protein-protein interactions. Nature 340:245-247.
12. Galcheva-Gargova Z, Konstantinov KN, Wu I-H, Klier FG, Barrett T, Davis RJ. 1996. Binding of zinc protein ZPR1 to the epidermal growth factor receptor. Science 272:1797-1802.
13. Gamett DC, Greene T, Wagreich AR, Kim H-H, Roland JG, Cerione RA. 1995. Heregulin-stimulated signaling in rat pheochromocytoma cells. J Biol Chem 270:19022-19027.
14. erbB3 possesses an impaired tyrosine kinase activity. Proc Natl Acad Sci USA 91:8132-8136.
15. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A. 1995. Signaling downstream of activated mammalian Notch. Nature 377: 355-358.
16. Jones FE, Jerry DJ, Guarino BC, Andrews GC, Stern DF. 1996. Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobulo-alveoli. Cell Growth Differ 7:1031-1038.
17. Kim H, Sierke SL, Koland JG. 1994. Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB-3 gene product. J Biol Chem 269:24747-24755.
18. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. 1989. Isolation and characterization of ERBB3, a third member of the ERBB1 epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci USA 86:9193-9197.
19. Lamartine I, Sen M, Cinti R, Iteitzmann F, Creaven M, Radomski N, Jost E, Lenoir GM, Romeo G, Sylla BS. 1997. Molecular cloning and mapping of a human cDNA (PA 2G4) that encodes a protein highly homologous to the mouse cell cycle protien p38-2G4. Cytogenet Cell Genet 78:31-35.
20. Lessor T, Yoo J-Y, Davis M, Hamburger AW. 1998. Regulation of Heregulin β1-induced differentiation in a human breast carcinoma cell line by the mitogen-activated protein kinase pathway. J Cell Biochem 70:587-595.
21. Lewis GD, Lofgren JA, McMurtey AE, Nuijens A, Fendly BM, Bauer KD, Sliwkowski MX. 1996. Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res 56:1456-1465.
22. Look DC, Pelletier MR, Tidwell RM, Roxwit WT, Holtzman MJ. 1995. Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 270:30264-30267.
23. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. 1995. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87:1215-1224.
24. Mancini MA, Shan B, Nickerson JA, Penman S, Lee W-H. 1994. The retinoblastoma gene product is a cell cycle-dependent nuclear matrix associated protein. Proc Natl Acad Sci USA 91:418-422.
25. Marikovsky M, Lavi S, Pinkas-Kramarski R, Karunagaran D, Liu N, Wen D, Yarden Y. 1995. ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene 10:1403-1411.
26. Marte BM, Graus-Porta D, Jeschke M, Fabbro D, Hynes NE, Taverna D 1995. NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. Oncogene 10:167-175.
27. Radomski N, Jost E. 1995. Molecular cloning of a murine cDNA encoding a novel protein, p38-2G4, which varies with the cell cycle. Exp Cell Res 220:434-445.
28. Rietmacher D, Sonnenberg RE, Brinkmann V, Yamaai T, Lewsin GR, Birchmeier C. 1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389:725-730.
29. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
30. Syroid DE, Maycox PR, Burrola GP, Liu N, We D, Lee K-F, Lemke G, Kilpatrick TJ. 1996. Cell death in the Schwann cell lineage and its regulation by neuregulin. Proc Natl Acad Sci USA 92:9229-9234.
31. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ, Yarden Y. 1996. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol Cell Biol 16:5276-5287.
32. Vartanian T, Goodearl A, Vichover A, Fischbach G. 1997. Axonal neuregulin signals through activation of HER4 and Schwann cells through HER2 and HER3. J Cell Biol 137:211-220.
33. Voraberger G, Schafer R, Stratowa C. 1991. Cloning of the human gene for intercellular adhesion molecule-1: an analysis of its 5′ regulatory region. J Immunol 147:2777-2786.
34. Yamada H, Mori H, Momoi H, Nakagawa Y, Ueguchi C, Mizuno T. 1994. A fission yeast gene encoding a protein that preferentially associates with curved DNA. Yeast 10:883-894.
35. Yang Y, Spitzer E, Meyer D, Sachs M, Niemann C, Hartmann G, Weidner KM, Birchmeier C, Birchmeier W. 1995. Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol 131:215-226.
36. Yoo J-Y, Lessor T, Hamburger AW. 1998. Inhibition of cell proliferation by 17β-estradiol and heregulin β1 in estrogen receptor negative human breast carcinoma cell lines. Breast Cancer Res Treat 51:71-81.
37. Yoo J-Y, Wang XW, Rishi AK, Lessor T, Xia X-M, Gustafson TA, Hamburger AW. Interaction of the PA2G4 (Ebp1) protein with ErbB-3 and regulation of this binding by heregulin. 2000. Br J Cancer 82:683-690.
38. Zhang K, Sun J, Liu N, Wen D, Chang D, Thomason A, Yoshinaga SK. 1996. Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 and HER2. J Biol Chem 271:3884-3890.